Global Diagnostic Imaging Devices Market - 2025-2033

The global diagnostic imaging devices market reached US$ 33.7 billion in 2024 and is expected to reach US$ 52.6 billion by 2033, growing at a CAGR of 5.1% during the forecast period 2025-2033.

Diagnostic imaging devices are medical technologies used to create visual representations of the interior of a body for clinical analysis and medical intervention. These devices play a critical role in diagnosing, monitoring, and treating various medical conditions by providing detailed images of organs, tissues, bones, and blood vessels. They are crucial tools in modern medicine, as they help healthcare providers identify diseases, determine the extent of an injury, monitor disease progression, and plan surgeries or treatments.

The global diagnostic imaging market is experiencing robust demand, driven by various factors such as increasing healthcare needs, technological advancements and the growing prevalence of chronic diseases. For instance, according to the Centers for Disease Control and Prevention, an estimated 129 million people in the US have at least 1 major chronic disease (e.g., heart disease, cancer, diabetes, obesity, hypertension) as defined by the US Department of Health and Human Services. Five of the top 10 leading causes of death in the US are or are strongly associated with preventable and treatable chronic diseases.

Market Dynamics: Drivers & Restraints

Rising technological advancements in diagnostic imaging devices

Rising technological advancements in diagnostic imaging devices are significantly driving the growth of the diagnostic imaging devices market and are expected to drive the market over the forecast period by improving diagnostic accuracy, efficiency and patient outcomes. These innovations not only enhance the capabilities of imaging systems but also expand their applications across various clinical disciplines.

AI and machine learning are revolutionizing diagnostic imaging by improving the speed and accuracy of image analysis. AI tools can quickly identify patterns in images, assist in detecting abnormalities and provide decision support to healthcare professionals. For instance, in December 2024, Royal Philips announced clinical decision-support with AI and smart workflow automation capabilities in the company's recently introduced CT 5300 system. Philips' CT Smart Workflow features a comprehensive suite of AI-enabled 'Precise' software solutions that assist at every step of the CT workflow, freeing technicians and radiologists from routine, time-consuming tasks and allowing them more time to focus on their patients.

Technologies like 3D MRI and 3D ultrasound have transformed how healthcare professionals visualize and diagnose conditions. These advancements are crucial for better surgical planning and monitoring of disease progression. For instance, in May 2024, Koelis, SAS released new features at the prestigious American Urological Association Annual Meeting to demonstrate its novel capacity to integrate AI-enhanced prostate MRI features into its exclusive Trinity platform. The Koelis Trinity system enables urologists to perform 3D targeted "fusion biopsy" in prostate cancer. Trinity integrates 3D ultrasound imaging with proprietary MRI-US fusion image guidance that features the Company's unique prostate motion tracking software (OBT Fusion).

Portable diagnostic imaging devices, such as handheld ultrasound machines, are improving access to care, especially in rural or underserved areas. These devices offer mobility, cost-effectiveness, and the ability to perform diagnostics at the point of care, reducing the need for patients to travel long distances to healthcare facilities.

For instance, in February 2023, Carestream Health India launched its high-powered Carestream Motion Mobile X-ray system. The system is fully equipped to carry out a full range of general radiography examinations. The new portable imaging system is compact and easy to maneuver into tight spaces. Innovative features such as a tube head and articulating arm for excellent visibility and easy use.

High cost of diagnostic imaging devices

The high cost of diagnostic imaging devices is expected to hamper the market growth, especially in emerging economies and small healthcare facilities. Diagnostic imaging devices such as MRI, CT scanners, and PET scanners require substantial upfront investments, which can be cost highly. This is a significant barrier, particularly for smaller healthcare centers or those in developing regions with limited financial resources.

For instance, according to Block Imaging, Inc., the average cost for a CT scanner varies significantly depending on the model and features, with prices ranging from $80,000 for basic models to up to $300,000 for premium. Typically, buyers can expect to spend between $120,000 and $160,000 for an intermediate-level CT scanner. The average cost of a PET/CT scanner can range from $225,000 for an entry-level scanner to $475,000 for an optimized scanning system. PET/CT scanners can go as high as $750,000 for the latest and greatest.

In addition to high upfront costs, these imaging devices have considerable ongoing maintenance and operational expenses. Regular servicing, software upgrades and repairs are required to keep the equipment functioning efficiently. This adds to the overall burden, especially in developing economies where hospitals and diagnostic centers may already be struggling with tight budgets.

Segment Analysis

The global diagnostic imaging devices market is segmented based on product type, imaging type, portability, application, end-user and region.

Product Type:

The PET/CT scanners segment is expected to dominate the diagnostic imaging devices market share

The PET/CT scanners segment is expected to dominate the global diagnostic imaging devices market. PET/CT scanners combine Positron Emission Tomography (PET) and Computed Tomography (CT), allowing physicians to obtain both functional and anatomical images in a single scan. This fusion of technologies enables on-site technological upgrades, more accurate detection, staging and monitoring of diseases.

For instance, in July 2024, Positron announced that the company is launching its NeuSight PET/CT 3D 64-slice scanner in the U.S. and North American markets. Suitable for both cardiology and oncology imaging, the NeuSight PET/CT scanner offers anatomic and functional imaging for heart, tumor and brain imaging studies.

Continuous advancements in PET/CT scanner technology are making these devices more efficient and accessible. Innovations such as higher-resolution imaging, faster scan times, and improved patient comfort are boosting the adoption of these devices. For instance, in June 2024, Siemens Healthineers unveiled its latest PET/CT scanner, cleared by the U.S. Food and Drug Administration and features a scalable axial field-of-view design that enables on-site technological upgrades without costly room renovations or impeding workflow.

Geographical Analysis

North America is expected to hold a significant position in the diagnostic imaging devices market share

North America is expected to hold the largest market share in the global diagnostic imaging devices market. North America especially the United States is often the first region to adopt new diagnostic imaging technologies, including advanced MRI systems, digital X-rays and AI-powered imaging devices along with the strong presence of major players. The early adoption of innovations allows North America countries to maintain their leadership in the global market.

For instance, in October 2024, FUJIFILM Healthcare Americas Corporation launched the Version 10 (v10) suite of innovations for the ECHELON Synergy 1.5T MRI system. ECHELON Synergy v10 deploys several cutting-edge technologies, including Synergy DLR Clear, Synergy Vision with StillShot and automated scanning process enhancements.

North America, particularly the United States hosts some of the world's largest diagnostic imaging device manufacturers, such as GE Healthcare, Philips Healthcare, Siemens Healthineers and Canon Medical Systems. These companies invest heavily in research and development (R&D) to create next-generation imaging systems that continue to push the boundaries of diagnostic capabilities.

For instance, in December 2024, GE HealthCare unveiled Sonic DL for 3D, a new deep-learning innovation for the company's imaging portfolio. GE HealthCare initially launched Sonic DL in 2023. The company says it provides up to 12 times scan acceleration while maintaining diagnostic quality. This latest enhancement brings the system to 3D volumetric imaging. GE HealthCare wants to broaden the platform's applicability to brain, spine, orthopedic and body exams in addition to cardiac.

Asia-Pacific is growing at the fastest pace in the diagnostic imaging devices market

The Asia-Pacific region is experiencing the fastest growth in the diagnostic imaging devices market. The region is rapidly adopting advanced diagnostic imaging technologies, including AI-powered imaging devices, portable ultrasound machines and hybrid systems (e.g., PET/CT). These innovations are making diagnostic imaging more efficient, affordable and accessible in the region.

For instance, in October 2023, Abbott launched its new vascular imaging platform powered by Ultreon 1.0 Software in India. This first-of-its-kind intra-vascular imaging software combines optical coherence tomography (OCT) with the power of artificial intelligence (AI) providing physicians a comprehensive view of blood flow and blockages within coronary arteries. The innovative imaging software can automatically differentiate between a calcified and non-calcified blockage, detect the severity of calcium-based blockages and measure vessel diameter.

Additionally, in July 2024, Trivitron Healthcare launched its Terrene CT scanner in India. The scanner has received approvals from the Bureau of Indian Standards, Atomic Energy Regulatory Board, and Central Drugs Standard Control Organization, marking a significant milestone in the Indian healthcare industry.

Competitive Landscape

The major global players in the diagnostic imaging devices market include Siemens Healthineers AG, GE HealthCare, Koninklijke Philips N.V., CANON MEDICAL SYSTEMS CORPORATION, FUJIFILM Holdings Corporation, Medtronic plc, Hologic, Inc., Abbott Laboratories, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Carestream Health and among others.

Key Developments

• In August 2024, Fischer Medical Ventures (FMVL) introduced indigenously developed Computed Tomography (CT) scans. The company developed India's first indigenous Magnetic Resonance Imaging (MRI) system. The company, celebrating its listing on the Bombay Stock Exchange (BSE), announced plans to introduce domestically produced CT scans in collaboration with Edusoft at half the price of current market offerings.
• In July 2024, LG Electronics (LG) announced that the company expanding its lineup of diagnostic monitors with the new 21HQ613D-B, which was recently cleared by the U.S. Food and Drug Administration for sale in the U.S. Intended for digital mammography and digital breast tomosynthesis, the 21HQ613D-B is a 21.3-inch 5-megapixel (MP) IPS diagnostic monitor designed to deliver high-definition radiological images and maintains consistent image quality through its internal front calibration sensor and calibration software.

Why Purchase the Report?

• Pipeline & Innovations: Reviews clinical trials, product pipelines, and future advancements in medical devices.
• Product Performance & Market Positioning: Analyzes product performance and market positioning to refine strategies.
• Real-World Evidence: Uses patient feedback and data to improve device outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and health system mergers' impact on adoption.
• Market Updates & Industry Changes: Covers regulatory changes, new policies, and emerging technologies in medical devices.
• Competitive Strategies: Analyzes competitor strategies, market share, and new entrants in the market.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and access strategies.
• Market Entry & Expansion: Identifies strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights regions with growth opportunities and investment potential.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and regulatory changes.
• Post-market Surveillance: Uses post-market data to enhance device safety and access.
• Cost-Effectiveness & Value-Based Healthcare: Analyzes cost-effectiveness and value-based models in device pricing and adoption.

The global diagnostic imaging devices market report delivers a detailed analysis with 78 key tables, more than 84 visually impactful figures, and 183 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.